Recently the potentiator ivacaftor was reported to significantly augment cAMP mediated ion transport activity of CFTR encoding the gating mutation, G551D-CFTR, in vitro[17] and in CF subjects harboring the G551D CFTR defect [16]. This evidence concerns the gene CFTR and cystic fibrosis.